跳至主要内容
临床试验/NCT01168492
NCT01168492已完成4 期

Analgesia During Pediatric Digestive Endoscopy: a Comparison of Two Protocols for Procedural Sedation

Université de Montréal1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2010年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
90
试验地点
1
主要终点
pain score

研究概览

简要总结

The purpose of this study is to determine whether ketamine, midazolam, and meperidine are more effective than midazolam and meperidine alone for procedural sedation and analgesia in pediatric digestive endoscopy. Secondary outcomes are the incidence of cardiorespiratory side effects and the necessity of rescue doses.

详细描述

90 patients will be included. The sedation will include 0.1mg/kg, max 5mg iv of midazolam, 1mg/kg, max 50mg iv of meperidine, and placebo (0.9%NaCl) or ketamine 0.5mg/kg iv. Rescue doses will be given as usual, using meperidine and or midazolam 50% of the initial dose.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
10 Years 至 19 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children =/> 10 years of age
  • Undergoing elective diagnostic colonoscopy
  • ASA score class 1-3.

排除标准

  • Children younger than 10 years of age
  • Known epilepsy under treatment
  • ASA score class 4 or more
  • Interventional colonoscopy (e.g.polypectomy)

研究组 & 干预措施

ketamine

Experimental

group with triple sedation (ketamine, midazolam, meperidine)

干预措施: ketamine (Drug)

placebo

Placebo Comparator

group with conventional sedation and placebo ( midazolam, meperidine and placebo)

干预措施: ketamine (Drug)

结局指标

主要结局

pain score

时间窗: after one year

pain scores are accorded at the end of each endoscopy. Pain scores of the two groups will be compared after one year

次要结局

  • necessity of cardiopulmonary intervention (Oxygen requirements)(after one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Denise Herzog

Associate Professor

Université de Montréal

研究点 (1)

Loading locations...

相似试验